Finance

Beta
Lists
4746:TPE
Formosa Laboratories Inc
NT$53,30
+2,11%
(+1,10) 1D
1 Jun., 13:30:24 GMT+8  ·   TWD
All symbols
SymbolPriceChange% Change
Generating top insights for 4746...
Open
NT$52,40
High
NT$53,80
Low
NT$51,30
Mkt. cap
6,41 mjd
Avg. vol.
1,08 m
Volume
1,49 m
P/E ratio
19,11
52-wk high
NT$72,50
52-wk low
NT$50,00
EPS
NT$2,79
Shares outstanding
99,01 m
No. of employees
480
Open
NT$52,40
High
NT$53,80
Low
NT$51,30
Mkt. cap
6,41 mjd
Avg. vol.
1,08 m
Volume
1,49 m
P/E ratio
19,11
52-wk high
NT$72,50
52-wk low
NT$50,00
EPS
NT$2,79
Shares outstanding
99,01 m
No. of employees
480
News stories
From sources across the web
About Formosa Laboratories Inc
CEO-
Employees480
Founded1985
Headquarters-
SectorPharmaceutical industry
Websiteformosalab.com
Previous reportsAll values in TWD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in TWD
Jun. 2025
Sep. 2025
Des. 2025
Mrt. 2026
Revenue
1,24 mjd
1,16 mjd
1,30 mjd
1,06 mjd
Cost of goods sold
725,80 m
668,85 m
761,78 m
606,66 m
Cost of revenue
725,80 m
668,85 m
761,78 m
606,66 m
Research and development expenses
204,90 m
173,66 m
172,00 m
186,06 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
130,73 m
139,89 m
120,93 m
125,15 m
Operating expense
340,66 m
337,14 m
263,70 m
306,56 m
Total operating expenses
1,07 mjd
1,01 mjd
1,03 mjd
913,22 m
Operating income
176,37 m
154,63 m
278,70 m
150,78 m
Other non operating income
49,62 m
1,54 m
-17,06 m
-96,23 m
EBT including unusual items
-123,68 m
339,36 m
135,78 m
50,30 m
EBT excluding unusual items
43,47 m
172,06 m
279,94 m
50,30 m
Income tax expense
4,20 m
42,45 m
9,70 m
35,33 m
Effective tax rate
-3,39%
12,51%
7,15%
70,25%
Other operating expenses
-
-
-
-
Net income
-150,86 m
324,10 m
147,32 m
18,76 m
Net profit margin
-12,14%
27,93%
11,30%
1,76%
Earnings per share
-1,25
2,68
-
-
Interest and investment income
10,36 m
6,68 m
8,72 m
5,76 m
Interest expense
-8,72 m
-7,10 m
-6,43 m
-7,07 m
Net interest expenses
1,63 m
-416,00 k
2,29 m
-1,31 m
Depreciation and amortization charges
-
-
-
-
EBITDA
294,31 m
282,41 m
440,33 m
293,13 m
Gain or loss from assets sale
-119,00 k
5,01 m
-5,19 m
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer